Gluck Center Study on Equine Proliferative Enteropathy
While equine proliferative enteropathy (EPE) is most commonly seen during the fall (October) and early winter (January), a recent study at the University of Kentucky Gluck Equine Research Center by David Horohov, PhD, William Robert Mills chair and professor at the Gluck Center, and Allen Page, DVM, a doctoral student and Morris Animal Foundation/Pfizer Animal Health fellow at the Gluck Center, revealed that in Central Kentucky, exposure to the disease’s causative bacterium can continue into March.
Equine proliferative enteropathy is an emerging equine disease that has been reported worldwide. The disease is caused by Lawsonia intracellularis, an obligate, intracellular, Gram-negative bacterium that invades intestinal crypt cells, primarily in the small intestine, and causes thickening of the intestinal lining. This thickening leads to clinical signs such as anorexia, weight loss, fever, lethargy, depression, peripheral/ventral edema (fluid swelling), and sometimes colic and diarrhea. A thickened small intestinal wall observed by a veterinarian via abdominal ultrasound is highly suggestive of EPE. Clinical EPE is typically found in weanlings and young yearlings, with only a few reports of older horses being affected.
Lawsonia intracellularis infections have been reported in a number of species, including pigs and laboratory animals, but not humans. The disease is significant not just because of its clinical aspects, but also because of its economic impact. A 2008 study by Michele Frazer, DVM, of Hagyard Equine Medical Institute, found that previously affected horses offered for public auction sold for 68% less than unaffected horses by the same sire.
The disease can be a frustrating problem for farms to deal with given the lack of definitive diagnostic tests, the sporadic occurrence of cases, and the unknown epidemiology of
Create a free account with TheHorse.com to view this content.
Stay on top of the most recent Horse Health news with